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Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters
but not recycling of fatty acid into phospholipid : evidence for functionally
separate pools of acyl-CoA
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The trafficking of acyl-CoAs within cells is poorly understood. In
order to determine whether newly synthesized acyl-CoAs are
equally available for the synthesis of all glycerolipids and
cholesterol esters, we incubated human fibroblasts with
["%C]oleate, [$H]arachidonate or [$H]glycerol in the presence or
absence of triacsin C, a fungal metabolite that is a competitive
inhibitor of acyl-CoA synthetase. Triacsin C inhibited de noo
synthesis from glycerol of triacylglycerol, diacylglycerol and
cholesterol esters by more than 93%, and the synthesis of
phospholipid by 83%. However, the incorporation of oleate or
arachidonate into phospholipids appeared to be relatively un-
impaired when triacsin was present. Diacylglycerol acyl-
transferase and lysophosphatidylcholine acyltransferase had
similar dependences on palmitoyl-CoA in both liver and fibro-
blasts ; thus it did not appear that acyl-CoAs, when present at
INTRODUCTION
Long-chain acyl-CoAs are substrates for de noo synthesis of
glycerolipids and cholesterol esters, reacylation of lysophospho-
lipids, and N-acylation of proteins and sphingosine. They are
also precursors for fatty acid elongation and desaturation
reactions and substrates for β-oxidation. Long-chain acyl-CoAs
function in vesicle trafficking within cells, and evidence obtained
in itro suggests that they play regulatory roles by inhibiting fatty
acid synthesis [1], activating protein kinase C [1], inhibiting the
nuclear thyroid hormone receptor [2] and regulating the ac-
tivation of O
#
−[ generation and degranulation of neutrophils [3].
These functions take place in different cellular compartments but
nothing is known about the partitioning of acyl-CoAs within
cells, although it has been hypothesized that acyl-CoAs that are
synthesized on the outer mitochondrial membrane and on the
peroxisomal membrane might be destined for oxidation, whereas
those synthesized in the endoplasmic reticulum might play
biosynthetic roles. This view fails to take into account the facts
that : (1) in addition to carnitine palmitoyltransferase I, which
channels acyl-CoAs towards β-oxidation, the outer mito-
chondrial membrane contains a glycerol-3-phosphate acyl-
transferase isoenzyme that is the committed step in glycerolipid
biosynthesis [4] ; (2) acyl-CoA-binding protein could transport
acyl-CoAs to different sites within cells [5] ; (3) peroxisomes can
use acyl-CoAs both for oxidation [2] and for the synthesis of
alkyl lipids [5]. Further, the problem of regulation of the
numerous individual acyltransferase functions within the en-
doplasmic reticulum remains unresolved.
In studying human fibroblasts to elucidate the biochemical
defect in neutral lipid storage disease [6], we used triacsin C, a
Abbreviations used: ACS, acyl-CoA synthetase ; C6-NBD, [6-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoic acid ; DGAT, diacylglycerol
acyltransferase ; FBS, fetal bovine serum; LPC-AT, lysophosphatidylcholine acyltransferase ; E-MEM, minimum essential medium with Earle salts plus
1% non-essential amino acids.
low concentrations, would be preferentially used to acylate
lysophospholipids. We interpret these data to mean that, when
fatty acid is not limiting, triacsin blocks the acylation of glycerol
3-phosphate and diacylglycerol, but not the reacylation of
lysophospholipids. Two explanations are possible : (1) different
acyl-CoA synthetases exist that vary in their sensitivity to triacsin;
(2) an independent mechanism channels acyl-CoA towards
phospholipid synthesis when little acyl-CoA is available. In
either case, the acyl-CoAs available to acylate cholesterol,
glycerol 3-phosphate, lysophosphatidic acid and diacylglycerol
and those acyl-CoAs that are used by lysophospholipid acyl-
transferases and by ceramide N-acyltransferase must reside in
two non-mixing acyl-CoA pools or, when acyl-CoAs are limiting,
they must be selectively channelled towards specific acyl-
transferase reactions.
potent competitive inhibitor of long-chain acyl-CoA synthetase
(ACS) [7,8] to block reuse of lipolysed fatty acids. Because our
results suggested that the presence of triacsin C inhibited de noo
synthesis of triacylglycerol and phospholipid from glycerol but
did not inhibit the acylation of phospholipids, we initiated
further studies to examine acylation in human fibroblasts. These




Silica-gel G plates were from Whatman. [2-$H]Glycerol,
[$H]palmitate, [1-"%C]oleate and [5,6,8,9,11,12,14,15-$H]arachi-
donic acid were from Amersham Life Sciences Co. Glycerol,
BSA (essentially fatty acid-free), phospholipase A
#
(Naja naja)
and sodium oleate were from Sigma. Lipid standards, lysophos-
phatidylcholine and sn-1,2-dioleoylglycerol were from Serdary.
Triacsin C (" 95% pure) was from Biomol Research
Laboratories. Tissue culture supplies and fetal bovine serum
(FBS) were from Gibco. [6-(7-Nitro-2,1,3-benzoxadiazol-4-
yl)amino]hexanoic acid (C6-NBD-PC), where PC is phospha-
tidylcholine, was from Avanti Polar Lipids.
Cell culture
Normal human skin fibroblasts were obtained from the American
Type Tissue Culture Collection (cell line CCD). Normal fibro-
blasts were cultured at 37 °C in a humidified atmosphere of 5%
CO
#
in minimum essential medium with Earle salts plus 1% non-
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essential amino acids (E-MEM) and 10% FBS that had been
heat inactivated for 60 min at 56 °C. The concentration of oleic
acid from FBS was 4 µM. The medium was changed every 2–3
days. For each experiment, total cellular DNA content was
measured fluorimetrically [9].
Dose–response of triacsin C on fatty acid incorporation into lipids
Normal fibroblasts were grown to near-confluence in 60 mm
dishes. Cells were incubated for 9 h with 0±25 µCi of [1-"%C]oleic
acid in the presence or absence of 100 µM unlabelled sodium
oleate. Monolayers were simultaneously treated with different
concentrations of triacsin C (from 0±25 to 10 µM) or its vehicle
(DMSO (0±1%, v}v). The incubation was terminated by dis-
carding the labelling medium, and washing the cells twice with
0±1% BSA in PBS at 37 °C. Fibroblasts were rapidly scraped
into two additions of 1 ml of methanol and one of 0±5 ml of
water. Chloroform (1 ml) was added and total cell lipids were
extracted [10] and concentrated using a SpeedVac concentrator
(Savant, Hicksville, NY, U.S.A.).
Pulse radiolabelling
Fibroblasts were seeded in 60 mm dishes and grown to confluence
and incubated with 0±5 µCi of [1-"%C]oleic acid, 2 µCi of [$H]gly-
cerol or 0±25 µCi of [$H]arachidonic acid in 2 ml of 10% FBS}E-
MEM. The labelling medium contained 0±1 mM unlabelled
sodium oleate or arachidonic acid to promote incorporation of
label into triacylglycerol. Sodium oleate was dissolved in water at
65 °C and added to dry ["%C]oleate. Then 1% BSA (final
concentration) in E-MEM was added. Monolayers were treated
with 5 µM triacsin C in DMSO (0±1%, v}v, final concentration).
Control cells received the vehicle alone. After 1, 3, 6 or 24 h, the
incubation was stopped by aspirating the medium. Residual
radiolabel was removed by washing the cells twice with 0±1%
BSA in PBS at 37 °C. Lipids were extracted and concentrated by
following the procedure described above.
[14C]Oleate incorporation into the sn-2 position of phospholipid
Fibroblasts were grown in 100 mm dishes to near-confluence and
incubated with 100 µM [1-"%C]oleic acid (0±5 µCi}dish) com-
plexed with 1% BSA in the same growing medium in the presence
or absence of 5 µM triacsin C. After 24 h the medium was
aspirated and the residual label was washed with 0±1% BSA in
PBS. Cells were scraped into methanol and lipids were extracted
as described above. The polar and neutral lipid fractions were
separated on silica-gel G plates in hexane}ethyl ether}acetic acid
(80:20:1, by vol.). Polar lipids, which remained at the origin,
were scraped from the plate and extracted twice from the silica
gel with chloroform}methanol (1 :1, v}v). The solvents were
dried and the phospholipids were diluted in 100 µl of DMSO.
Half of each sample was treated with buffer alone (50 µM Tris,
pH 8±6, 25 mM CaCl
#
, 1 mM EDTA) and half with 800 units of
phospholipase A
#
in 100 µl of buffer. The incubation was
performed at 37 °C in an orbital shaker for 1 h. The reaction was
stopped by adding 1±5 ml of chloroform}methanol (1 :2, v}v),
and lipids were extracted [10]. The lipid extracts were then
chromatographed with hexane}ethyl ether}acetic acid (80:20:1,
by vol.) in order to separate unesterified fatty acid from total
polar lipids. The percentage of fatty acids released from phospho-
lipid was calculated after scanning the plate in a Bioscan
Image System. To determine whether the phospholipase A
#
hydrolysis was complete under these conditions and to check the
specificity of the enzyme, we incubated C6-NBD-PC (which
contains the fluorescent fatty acid analogue C6-NBD in the sn-
2 position) under the same conditions. The C6-NBD fluorophore
was released completely and no fluorescent sn-2-lysophos-
phatidylcholine was detected after chromatography in a uni-
directional two-solvent system [6]. These data indicate that the
phospholipase A
#
acted specifically and completely on the sn-2
position.
Lipid analysis
Aliquots of the lipid extracts were spotted on 0±25 mm silica-gel
G plates. Neutral and polar lipids were resolved in the same plate
by a combination of a one-directional double-solvent system.
First, phospholipidswere separatedby running the chromatoplate
in chloroform}methanol}ammonium hydroxide (65:25:4, by
vol.) to 8 cm from the top. Then the residual solvents on the plate
were evaporated under a stream of N
#
. To resolve neutral lipid
species, the plate was rerun in the same direction to the top in
heptane}isopropyl ether}acetic acid (60:40:4, by vol.), in order.
Samples were chromatographed in parallel with authentic
standards. Lipid products labelled with $H or "%C were visualized
using a BioScan Image 200 System (Washington, DC, U.S.A.).
The $H-labelled spots were scraped into vials and counted in a
liquid-scintillationcounter.The "%C-labelled spotswerequantified
by the BioScan 200 system.
Enzyme assays
In order to compare dependence on palmitoyl-CoA of diacyl-
glycerol acyltransferase (DGAT) and lysophosphatidylcholine
acyltransferase (LPC-AT) under the same conditions, we assayed
each of these activities in 175 mM Tris}HCl, pH 8±0, containing
8 mM MgCl
#
, 1 mg}ml BSA, 50 µM lysophosphatidylcholine,
200 µM sn-1,2-dioleoylglycerol in acetone (2±5% of the final
200 µl volume) and 30 µg of microsomal protein for liver or
30 µg of total particulate protein for fibroblasts. Forty-minute
assays were started by adding 30 µM [$H]palmitoyl-CoA. For
DGAT, the reaction product was extracted into heptane [11].
For LPC-AT, the reaction was stopped by adding 4 ml of cold
chloroform}methanol (2 :1, v}v), then water (800 µl) to break
the phases. The tubes were vortex-mixed and centrifuged at
1100 g for 10 min, and the upper phase was discarded. The lower
phase was washed twice with 2 ml of water. An aliquot was
counted and the remainder was evaporated in a Speed-Vac
Concentrator and chromatographed on silica-gel G plates in
hexane}ethyl ether}acetic acid (80:20:1, by vol.) with authentic
standards. Phosphatidylcholine (" 90% of the labelled phos-
pholipid product) and other products were scraped off and
counted and the specific radioactivity was calculated. Both assays
measured initial rates.
Other methods
Near-confluent fibroblasts were scraped from the
dishes and total particulate preparations were obtained and
stored at ®80 °C [6]. KCl-washed liver microsomes from 200 g
Sprague–Dawley rats were obtained [12] and stored at ®80 °C.
ACS was assayed using 10–30 µg of total particulate protein and
50 µM ["%C]oleate as described [13]. [$H]Palmitoyl-CoA was
synthesized enzymically [14].
RESULTS
Triacsin inhibition of oleate incorporation into lipid
ACS activity was 0±92 nmol}min per mg of protein in total
particulate preparations from human fibroblasts. This activity
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Figure 1 Incorporation of [14C]oleate into (A) triacylglycerol and phospho-
lipid and (B) fatty acid and cholesterol ester in the presence of various
concentrations of triacsin C
Preconfluent cells were incubated for 9 h with 100 µM [14C]oleate in the presence of various
concentrations of triacsin C, as indicated. Each data point represents the mean³S.D. from
triplicate samples. Some error bars are hidden by the symbol.
Figure 2 Incorporation of a low concentration of fatty acid into (A)
triacylglycerol and phospholipid and (B) diacylglycerol and fatty acid in the
presence of different concentrations of triacsin C
Confluent cells were incubated for 9 h with 2 µM [14C]oleate plus concentrations of triacsin C
as indicated. Each data point represents the mean³S.D. from triplicate samples. Some error
bars are hidden by the symbol.
was inhibited by 68% in the presence of 5 µM triacsin C. In a 9 h
incubation with 100 µM oleate, the ACS inhibitor triacsin C
(0±25 µM) inhibited ["%C]oleate incorporation into total glycero-
lipid by 40% (Figure 1A). Maximal inhibition of 57% was
observed when 10 µM triacsin C was present. Analysis of the
glycerolipids formed demonstrated that incorporation of oleate
into triacylglycerol was inhibited by 80 and 91% in the presence
of 0±25 and 10 µM triacsin C respectively (Figure 1A), and
incorporation of ["%C]oleate into cholesterol ester was inhibited
by 75 and 91% by 0±25 and 10 µM triacsin respectively (Figure
1B). No change was observed in labelled fatty acid. In contrast,
["%C]oleate incorporation into phospholipid was not affected
(Figure 1A). This experiment suggested that some acyl-CoA was
formed in the presence of triacsin C, but that this acyl-CoA pool
was available for the synthesis of phospholipid, but not of
triacylglycerol or cholesterol esters.
In order to determine whether the relative distribution of
esterified fatty acid would be different if only a small amount of
fatty acid were available to the cells, the experiment was repeated
with 2 µM ["%C]oleate. When the amount of fatty acid was
limited, the incorporation of label into triacylglycerol relative to
phospholipid was markedly inhibited (Figure 2A). Triacsin C at
Figure 3 Time course of glycerol incorporation into triacylglycerol (TG ; top
left), phospholipid (PL, top right) or diacylglycerol (DAG, bottom) in the
presence and absence of triacsin C
Cells were incubated with 2 µCi of [3H]glycerol and 100 µM oleate plus or minus 5 µM
triacsin C for up to 6 h. Each data point represents the mean³S.D. from triplicate samples.
Some error bars are hidden by the symbol.
0±25 or 10 µM inhibited incorporation of label into triacylglycerol
by 91 and 99% respectively, but decreased incorporation into
phospholipid by only 46 and 70% respectively. The high specific
radioactivity of the label allowed labelled diacylglycerol to be
measured (Figure 2B). Incorporation of label into diacylglycerol
decreased by 78 and 93% in the presence of 0±25 and 10 µM
triacsin respectively, whereas the amount of labelled cellular
unesterified fatty acid did not change. Labelled monoacylglycerol
was not detected. This degree of inhibition suggests that triacsin
C blocks diacylglycerol and triacylglycerol formation almost
totally whereas phospholipid synthesis is maintained selectively
even with limited fatty acid availability. The experiment also
suggests that either the de noo synthesis of diacylglycerol from
glycerol 3-phosphate is severely impaired under these conditions
or that any diacylglycerol formed is rapidly depleted.
Inhibition of de novo glycerolipid synthesis by triacsin C
We previously reported that when cells are incubated for 24 h,
5 µM triacsin C inhibits [$H]glycerol incorporation into triacyl-
glycerol by 99% and into phospholipid by 83% [6]. In order to
examine the effect of triacsin C at early time points, we incubated
cells with [$H]glycerol in the presence or absence of 5 µM triacsin
C for up to 6 h (Figure 3). Triacsin inhibited the incorporation
of [$H]glycerol into diacylglycerol and triacylglycerol by more
than 95% and into phospholipid by an average of 70% over the
6 h period. These studies suggest that triacsin C blocks de noo
synthesis of glycerolipids and the acylation of diacylglycerol to
form triacylglycerol. With de noo synthesis of phospholipids
blocked by 70–80% during the first 3 hours of incubation, any
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Figure 4 Time course of oleate incorporation into cell lipids in the
presence and absence of triacsin C
(A) Phospholipid (PL) and triacylglycerol (TG) ; (B) phosphatidylcholine (PC) and phosphatidyl-
ethanolamine (PE) ; (C) sphingomyelin (Sph) and phosphatidylinositol (PI)/phosphatidylserine
(PS) ; (D) fatty acid (FA) and diacylglycerol (DAG). Cells were incubated with 100 µM
[14C]oleate plus or minus 5 µM triacsin C for up to 24 h. Each data point represents the
mean³S.D. from triplicate samples. Some error bars are hidden by the symbol.
major incorporation of labelled fatty acid into phospholipid
could occur only by reacylation of existing lysophospholipids.
This hypothesis, that exogenous fatty acid is incorporated into
phospholipids by acylation of lysophospholipid species in the
presence and absence of triacsin C, was checked by examining
the incorporation of ["%C]oleate into the sn-2 position of phos-
pholipids. When the fatty acid in the sn-2 position of cell
phospholipids was released by phospholipase A
#
, 71±8% of the
["%C]oleic acid was released from phospholipid from untreated
cells and 73±9% from phospholipids from cells treated with
triacsin C. These data indicate that most of the labelled fatty acid
incorporated into phospholipid by these near-confluent cells was
used to reacylate sn-l-lysophospholipids and that the proportion
of label in the sn-2 position was not altered in the presence of
triacsin C.
Time course of inhibition by triacsin C
In order to determine whether triacsin C varied in its effects on
the synthesis of different phospholipid species, confluent fibro-
blasts were incubated for up to 24 h with ["%C]oleate. Triacsin C
inhibited oleate incorporation into phospholipid and triacyl-
glycerol by 62% at 1 h and by 65% at 24 h (Figure 4A). Most
of the decrease was the result of a complete inhibition of
triacylglycerol synthesis from labelled oleate (Figure 4A). In
contrast, incorporationof ["%C]oleate intophospholipiddecreased
by only 13%. In the presence of the ACS inhibitor, incorporation
Table 1 Incorporation of [14C]oleate or [3H]arachidonate into cholesterol
esters in the presence or absence of triacsin C
Cell lipids were extracted and analysed at 24 h. Each data point represents the mean³S.D.
from triplicate samples.
Cholesterol esters (nmol/µg of DNA)
Fatty acid (100 µM) No addition 5 µM Triacsin C
18 :1, n®9 0±446³0±036 0±016³0±001
20 :4, n®6 0±304³0±013 0±029³0±002
Figure 5 Incorporation of [3H]arachidonate into neutral lipid
Cells were incubated with 100 µM [3H]arachidonate in the presence or absence of 5 µM
triacsin C. At various time points cell lipids were analysed for (A) phospholipid (PL) and
triacylglycerol (TG), (B) fatty acid (FA) and diacylglycerol (DAG), (C) phosphatidylcholine (PC)
and phosphatidylethanolamine (PE) or (D) phosphatidylinositol (PI)/phosphatidylserine (PS).
Each data point represents the mean³S.D. from triplicate samples. Some error bars are hidden
by the symbol.
of ["%C]oleic acid into phosphatidylcholine and phosphatidyl-
ethanolamine decreased by 30 and 60% respectively (Figure 4B),
whereas incorporation into sphingomyelin and phosphatidyl-
serine}phosphatidylinositol increased 1±4-fold and 0±7-fold re-
spectively, compared with non-treated control cells (Figure 4C).
These data suggest that, in confluent human fibroblasts, turnover
of sphingomyelin and PI}PS may either be more rapid than that
of phosphatidylcholine and phosphatidylethanolamine or that
independent lysophospholipid acyltransferases and acyl-CoAs
exist for each phospholipid species.
The cellular content of labelled unesterified fatty acid did not
change in the presence of triacsin C (Figure 4D), suggesting that
when acyl-CoA synthesis is blocked, the amount of fatty acid
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Figure 6 Dependence of DGAT and LPC-AT on palmitoyl-CoA
Activities were measured under identical conditions with various amounts of palmitoyl-CoA as
indicated (A) liver KCl-washed microsomes, (B) and (C) human fibroblast total particulate
fractions.
entering cells is equal to the amount leaving. The extremely low
amount of label incorporated into diacylglycerol in control cells
was inhibited completely in the presence of triacsin, again
reflecting the block in de noo biosynthesis from glycerol 3-
phosphate (Figure 4D). Likewise, triacsin C inhibited the in-
corporation of ["%C]oleate into cholesterol esters by 96% at 24 h
(Table 1).





mouse fibrosarcoma cells, triacsin C inhibits
activation of arachidonate by ACS less well than it inhibits oleate
activation [15]. To determine whether this difference would also
be observed into fibroblasts, we incubated cells for 24 h with
100 µM [$H]arachidonate. Unlike oleate incorporation which
labelled triacylglycerol and phospholipid equally (Figure 1A),
arachidonate incorporation into triacylglycerol reached a plateau
at 6 h and the amount of arachidonate-labelled triacylglycerol
was only 25% of the amount of labelled phospholipid (Fig-
ure 5A). At 24 h, triacsin C inhibited the incorporation of
[$H]arachidonate into triacylglycerol (Figure 5A) and cholesterol
ester (Table 1) by 95 and 90% respectively,whereas incorporation
into total phospholipidwas unaffected (Figure 5A). Arachidonate
incorporation into diacylglycerol was inhibited by 63% by
triacsin at 24 h (Figure 5B), suggesting that the block in de noo
synthesis of diacylglycerol was less than with oleate or that the
cells used arachidonate-labelled diacylglycerol poorly. Incor-
poration of arachidonate into total phospholipid was the same in
the presence or the absence of triacsin C and no differences were
observed in PI}PS (Figures 5A and 5D). Triacsin altered label
incorporation into phosphatidylcholine and phosphatidyl-
ethanolamine only between 6 and 24 h (Figure 5C). With
[$H]arachidonate, no labelled sphingomyelin was observed.
If the K
m
values for the lysophospholipid acyltransferase
activities were markedly lower than that for DGAT activity,
reacylation of lysophospholipids would predominate over acyl-
ation of diacylglycerol if acyl-CoA availability were limiting. To
determine whether our results might be due to differences in
palmitoyl-CoA dependence rather than to separate acyl-CoA
pools, we assayed DGAT and a representative lysophospholipid
acyltransferase, LPC-AT, under identical conditions (Figure 6).
In liver microsomes, maximal activity was observed with 40 µM
palmitoyl-CoA for both activities and dependence on palmitoyl-
CoA was almost identical. In fibroblast total particulate prep-
arations, however, similar lags in activity for both DGAT and
LPC-AT were observed at low palmitoyl-CoA concentrations.
Although the specific activity of LPC-AT in fibroblasts was 10-
fold higher than that for DGAT, the activity ratios were similar
at high and low concentrations of palmitoyl-CoA. These data
strongly suggest that large differences do not exist in the affinities
of these enzymes for their acyl-CoA substrates and that such
differences cannot explain the preservation of ["%C]oleate incor-
poration into phospholipid at a time when incorporation into
triacylglycerol has been inhibited almost entirely.
DISCUSSION
Long-chain fatty acyl-CoAs are amphipathic molecules that
associate primarily with membranes [2,16], but it is not known
whether the dispersal of acyl-CoAs within cell membranes is
uniform or whether they accumulate in specific membranes or at
specific membrane regions. Acyl-CoAs cannot permeate the
endoplasmic reticulum and thus bind to acyltransferase active
sites that face the cytosolic surface [17]. Movement of acyl-CoAs
is probably unconstrained within the outer phospholipid mono-
layer. Thus it is generally assumed that newly synthesized acyl-
CoAs can move freely within cell membrane monolayers and
have free access to any of the acyltransferases present in that
membrane. Although it is unknown whether an acyl-CoA that
has been synthesized within a specific membrane can move to
another membrane, long-chain acyl-CoAs are, in fact, water-
soluble and could theoretically move through cytosol either free
or bound to a protein such as the acyl-CoA-binding protein [5].
Our studies indicate that this view of acyl-CoA trafficking is
incomplete. We have shown in human fibroblasts that, although
5 µM triacsin C inhibits de noo synthesis of triacylglycerol by
99% and phospholipid by 83% from glycerol, the incorporation
of labelled oleate into phospholipid is relatively unimpaired
when triacsin is present. We interpret these data to mean that
reacylation of lysophospholipids is not inhibited by triacsin when
fatty acid is not limiting. Two explanations are possible : (1)
different ACSs exist that vary in their sensitivity to triacsin; (2)
an independent mechanism channels acyl-CoA towards phospho-
lipid synthesis when little acyl-CoA is available. If incorporation
occurred because of the presence of a specific uninhibited ACS,
one might hypothesize that a triacsin-sensitive ACS synthesizes
acyl-CoAs that can only be used to acylate cholesterol, glycerol
3-phosphate, lysophosphatidic acid and diacylglycerol, and that
a second, triacsin-resistant, ACS synthesizes acyl-CoAs that can
only be used by lysophospholipid acyltransferases and by
ceramide N-acyltransferase. The two acyl-CoA pools would not
mix. The alternative possibility is that one or all ACSs are
inhibited only partially by triacsin C, thereby limiting the total
amount of acyl-CoA produced, and that this acyl-CoA is used
only to reacylate lysophospholipid; it is not available for the
processes of de noo glycerolipid synthesis, the synthesis of
triacylglycerol from diacylglycerol, or the synthesis of cholesterol
esters from cholesterol. In either case, however, the data imply
that acyl-CoAs are functionally channelled towards selected
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acyltransferase reactions. Decreases in the synthesis of phospha-
tidylcholine and phosphatidylethanolamine and increases in
phosphatidylinositol and sphingomyelin in the presence of
triacsin imply that there are further constraints on the use of the
limited amount of acyl-CoA. Such channelling into different
lipid pathways could occur by means of transport proteins such
as the acyl-CoA-binding protein [5], multienzyme complexes, or
because lysophospholipid acyltransferases and a triacsin-resistant
ACS are located together in a membrane other than the
endoplasmic reticulum.
Existing information does not provide support at present for
triacsin-sensitive and -resistant long-chain ACSs in mammalian
tissues. Three different long-chain ACSs have been identified in
rats, one associated with the endoplasmic reticulum, mito-
chondrial outer membrane, nuclear membrane and peroxisomal
membrane that activates saturated fatty acids of 10–20 carbons
and unsaturated fatty acids of 16–20 carbons [2,18], one cloned
from rat brain, the location and substrate specificity of which
have not been characterized [19] and one in the peroxisomal
matrix that activates very-long-chain fatty acids [20]. Although
they have multiple promoters that mediate expression [21,22],
long-chain ACSs from rat liver mitochondria, endoplasmic
reticulum and peroxisomes are identical immunologically and
have the same molecular mass, amino acid composition and pH
optimum [2]. It therefore seems unlikely that they would vary
substantially in their sensitivity to triacsin C. The differential
sensitivity to triacsin apparent in the ACSs that activate oleate
and arachidonate does not explain the fact that both oleoyl-CoA
and arachidonoyl-CoA are used primarily for phospholipid and
not triacylglycerol synthesis.
The situation differs in yeast. There four separate ACSs have
been purified and cloned, and the presence of an additional
peroxisomal ACS has been inferred [23]. Extensive genetic studies
have demonstrated varying susceptibility of the cloned ACSs to
inhibition by triacsin C, different preferences for fatty acid chain
length, and differences in the ability of the ACSs to activate
exogenously added fatty acids [22,24,25]. Only two of these
ACSs can activate exogenous fatty acids and overcome growth
arrest after fatty acid synthesis is blocked by cerulenin, implying
a high degree of compartmentalization of acyl-CoA metabolism
[24].Despite this information, it is not known inwhichmembranes
each of these ACSs is located or whether specific ACSs provide
substrates for specific acyltransferase reactions.
Triacsin C is a competitive inhibitor of ACS with respect to its
fatty acid substrate [7]. The IC
&!
appears to vary in different
tissues [8], and cultured cells respond differently. In Raji cells
incubated for 2 days with 1±0 µM triacsin C, growth was inhibited
by 50%, and the incorporation of ["%C]oleate into phosphatidyl-
choline, phosphatidylethanolamine and triacylglycerol was
inhibited similarly during a 20 min incubation [8]. After 3–4 days
of exposure to triacsin C at 4±8 µM, Raji cells were killed. In
contrast, 5 µM triacsin C had no discernible effect on the survival
of human fibroblasts for 4 days [6], and the present study shows
that the drug differed in its effects on the incorporation of fatty
acid into phospholipid and triacylglycerol, severely inhibiting the
latter. Compared with our studies in fibroblasts, the Raji cells
were exposed to lower concentrations of oleate, which may
Received 26 September 1996/16 January 1997 ; accepted 5 February 1997
protect cells exposed to the competitive ACS inhibitor. In
addition, the effect of triacsin may be more toxic in rapidly
growing cells. Human fibroblasts, which when dividing have a
doubling time of more than 2 days (R. A. Coleman, unpublished
work), were studied when confluent, whereas the proliferating





mouse fibrosarcoma cells, triacsin C at 40 µg}ml
(190 µM) for 1 h inhibited cell uptake of arachidonate and
oleate ; at 4±7 µM, triacsin C inhibited long-chain ACS by 90%




mouse fibrosarcoma cells, 4±7 µM
triacsin inhibited ACS maximally by 2 min [15]. In liver, 12±5 µM
triacsin D (less than 20 times as potent an ACS inhibitor as
triacsin C [8]) for 1 h inhibited very-low-density lipoprotein and
oleate stimulation of triacylglycerol synthesis from glycerol but,
unlike our studies, did not block the synthesis of cholesterol
esters from ["%C]acetate [26]. Thus different tissues may have
different complements of ACSs.
This study was supported by a grant from the National Institutes of Health HD 19068.
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